Well, there are very few people who have a better insight here than Peter Rossing who heads Complications Research at Steno Diabetes Center Copenhagen. He draws attention to younger people as well as to those living with type 1 diabetes, and to the mechanisms of action of popular drugs – a question that we frequently see in this format.